drugset / Trial / NCT00768326
Efficacy of Lu 31-130 in Patients With Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose with the study is to evaluate the efficacy and safety of Lu 31-130 in patients suffering from schizophrenia compared to placebo.
Timeline
- Start
- 2007-03
- Primary completion
- 2009-10
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zicronapine | Small molecule | 3 mg | Oral |
| Subject | Zicronapine | Small molecule | 5 mg | Oral |
| Subject | Zicronapine | Small molecule | 7 mg | Oral |
| Subject | Zicronapine | Small molecule | 10 mg | Oral |
| Subject | Zicronapine | Small molecule | 14 mg | Oral |